Weight Loss — Unintentional Algorithm

The full reasoning pathway — unintentional weight loss is a high-yield cancer marker: quantify it, screen localising red flags, investigate broadly and in parallel (not in series), sort malignant / organic / psychosocial, act on findings and safety-net.StartDecisionInvestigateActionReferStop / Admit

PresentationUnintentional weight loss

Quantify (>5% body weight over 6–12 months is significant; confirm objectively). Appetite, GI/systemic symptoms, mood, drugs, social circumstances. Examine fully — lymph nodes, abdomen/masses, breast, testes, respiratory.

Step 1 · Safety — localising cancer red flagsAny site-specific feature?

GI — dysphagia, rectal bleeding, change in bowel habit, abdominal mass, jaundice
Respiratory — haemoptysis, persistent cough, chest signs
Haematological — lymphadenopathy, bruising, night sweats, bone pain
Urological/gynae — haematuria, postmenopausal bleeding, pelvic mass

YES — localising flag

Stop · escalateSite-specific 2WW

Direct to the relevant urgent suspected-cancer pathway based on the localising feature (lung/colorectal/upper-GI/haematology/urology, etc.).

NO localising feature

Step 2 · InvestigateBroad first-line panel — in parallel

FBC, ferritin, U&E, LFT, calcium, glucose/HbA1c, TFT, CRP/ESR, coeliac serology, CXR, urinalysis, FIT; consider CA-125 / PSA, myeloma screen, HIV. Order together, not one at a time.

Step 3 · which category?

Malignancy

Must exclude

GI, lung, haematological (lymphoma/myeloma), renal, pancreatic, ovarian/prostate — the priority to exclude.

Organic non-cancer

Systemic

Hyperthyroidism, uncontrolled diabetes, chronic infection (TB, HIV), organ failure (cardiac/renal/COPD), IBD/coeliac/malabsorption.

Psychosocial

Common & treatable

Depression, dementia, eating disorder, social isolation/poverty (food insecurity), alcohol/substance use, polypharmacy.

Step 7 · act on findings

Step 7 · Action — treat the cause + supportCause-directed, nutrition alongside

Abnormal results → relevant pathway (cancer 2WW, endocrine, gastro, ID/TB-HIV).
Nutritional support: dietitian, oral nutritional supplements, treat reversible causes of poor intake (oral health, swallowing, nausea).
Psychosocial: treat depression, dementia support, eating-disorder pathway, social prescribing/food support, alcohol services.
Medication review — culprit drugs (metformin, SSRIs, stimulants) and appetite-affecting agents.

Step 6 · escalation thresholds

Step 6 · Refer — 2WW · NICE NG12Don't sit on it

NG12 supports urgent investigation/referral for unexplained weight loss with other features — low threshold for imaging and site-specific pathways.
Arrange parallel rather than sequential testing; if first-line panel is normal but loss continues, consider CT chest/abdomen/pelvis and specialist referral.
Refer per the abnormal result (haematology for paraprotein/cytopenia, gastro, endocrine, etc.).

Step 8 · nutrition & modifiable factors

Step 8 · Nutrition & supportAddress intake & circumstances

Food-first fortification and regular meals/snacks · dietitian and oral nutritional supplements · address dentition, dysphagia, nausea and social factors (shopping/cooking, finances, isolation) · alcohol reduction · optimise diabetes/thyroid; review appetite-suppressing drugs.

Step 9 · monitor & safety-net

Step 9 · Monitoring & safety-netWhen to come back

Monitor weight objectively and re-review at a defined interval (e.g. 4–6 weeks). If weight loss continues despite a normal first-line panel, escalate to CT and specialist review — do not reassure on normal initial bloods alone. Return sooner if new localising symptoms (bleeding, dysphagia, lumps) develop.

⚠️ Investigate in parallel, not in series: unexplained weight loss is among the strongest predictors of undiagnosed cancer — order a broad panel up front, and if it is normal but the weight keeps falling, image (CT-CAP) rather than reassure.

Safety

Red Flags — Cancer Until Proven Otherwise

Done

Unintentional weight loss ≥5% in 6–12 months is significant. Malignancy is found in 25% of referred cases. Investigate all.

Weight loss + dysphagia Oesophageal / gastric cancer → 2WW upper GI endoscopy. Any age with dysphagia = urgent.

Weight loss + rectal bleeding / altered bowel habit Age ≥40 → 2WW colorectal cancer

Weight loss + haematuria Age ≥45 → 2WW urology (renal cell carcinoma, transitional cell carcinoma)

Weight loss + haemoptysis Any age → 2WW lung cancer + urgent CXR

Weight loss + jaundice Pancreatic / biliary / hepatic malignancy → 2WW + urgent LFTs / USS abdomen

Night sweats + lymphadenopathy Haematological malignancy (lymphoma) → 2WW haematology

Bone pain + weight loss Myeloma, bony metastases → urgent serum protein electrophoresis + calcium + bone profile

Postmenopausal bleeding + weight loss Endometrial / ovarian cancer → 2WW gynaecology

NICE NG12 (Suspected Cancer Referral, 2015 updated 2023) mandates 2WW referral pathways for specific symptom combinations with weight loss. Unintentional weight loss has a positive predictive value for cancer of 2–5% as an isolated symptom, rising to 15–25% when combined with organ-specific symptoms (dysphagia, haemoptysis, rectal bleeding). Malignancy is the cause in approximately 25% of unintentional weight loss presentations that are investigated — GPs should have a low threshold for 2WW referral given the mortality benefit of early-stage cancer treatment.

Diagnose

Quantify & Characterise — History

Done

Quantify weight loss

Weigh patient now — compare to recorded weights. >5% loss in 6 months is clinically significant. >10% in 6 months = severe (urgent investigation regardless of cause)

Intentional or not?

Dietary change, increased exercise, GLP-1 agonists, new medication — confirm unintentional before investigating. If intentional + disordered pattern → eating disorder screen

Appetite

Preserved appetite + weight loss → malabsorption (coeliac, IBD, pancreatic insufficiency), diabetes, hyperthyroidism. Reduced appetite → depression, malignancy, infection

GI symptoms

Dysphagia, vomiting, diarrhoea, steatorrhoea (pale, floating, offensive stool = malabsorption), PR bleeding, change in bowel habit

Systemic symptoms

Fever, night sweats, fatigue (B-symptoms → haematological malignancy). Polydipsia / polyuria (diabetes). Tremor, heat intolerance, palpitations (hyperthyroidism)

Psychosocial

Depression (most common non-organic cause in elderly), anxiety, social isolation, financial difficulties (food insecurity), bereavement, dementia (forgetting to eat)

Preserved appetite with weight loss strongly suggests a hypermetabolic state (hyperthyroidism, uncontrolled diabetes) or malabsorption rather than malignancy or depression. This distinction narrows the differential significantly. Steatorrhoea (the hallmark of fat malabsorption) is a key symptom patients rarely volunteer — direct questioning is needed. In elderly patients, depression is the most common cause of unintentional weight loss (accounting for 25–30% of cases) and is frequently missed — direct PHQ-9 screening is essential.

Diagnose

Differential Diagnosis Framework

Done

Malignancy (25%)

Most common in over 50s. Any organ system. Weight loss can precede other symptoms by months. Low threshold for 2WW if over 40 + weight loss + any alarm symptom.

Non-malignant organic (25%)

Hyperthyroidism, uncontrolled diabetes (type 1 or 2), Addison's disease, COPD, heart failure, CKD, cirrhosis, IBD, coeliac disease, TB, HIV, chronic infection

Psychiatric (25%)

Depression (most common in elderly), anxiety, anorexia nervosa / ARFID (all ages), late-onset psychosis, substance misuse (alcohol, stimulants)

Malabsorption

Coeliac disease (preserved appetite + diarrhoea + fatigue), exocrine pancreatic insufficiency, small bowel bacterial overgrowth, post-surgical (gastrectomy, short bowel)

Medication-related

GLP-1 agonists (semaglutide, liraglutide), SGLT2 inhibitors, metformin (nausea), SSRIs initially, stimulants, digoxin toxicity, opioids (nausea)

Social / no cause (25%)

After full investigation, 25% remain unexplained — these require monitoring as cancer risk is still elevated for 12–24 months post-investigation

The classic teaching is that unintentional weight loss is caused approximately equally by malignancy, non-malignant organic disease, psychiatric/social causes, and unexplained causes — each ~25%. This distribution means that even after thorough investigation, a significant minority remain unexplained and still require cancer surveillance over 12–24 months (annual 2WW risk is elevated). Coeliac disease accounts for 1% of UK adults and is frequently diagnosed late — anti-TTG should be checked in all presentations with preserved appetite + weight loss.

Diagnose

Targeted Examination

Done

Weight & BMI

Weigh and calculate BMI. Document BMI — if <17.5 with distorted body image → anorexia nervosa. Assess muscle mass (MUAC) if frail.

General appearance

Cachexia (muscle wasting + fat loss), lymphadenopathy, jaundice, pallor, clubbing, oedema

Thyroid

Goitre, tremor, lid lag, warm peripheries, AF — hyperthyroidism. Weight loss with preserved appetite + palpitations → TFTs urgently

Abdominal exam

Hepatomegaly (metastases, cirrhosis, haematological), splenomegaly (haematological malignancy, portal hypertension), masses, ascites, PR examination

Lymph nodes

Cervical, axillary, inguinal, supraclavicular (Virchow's node — left supraclavicular = upper GI malignancy, highly significant)

Rectal exam

Rectal mass, blood on examining finger — mandatory in weight loss + bowel symptoms in age >40

Breasts / testes

In age-appropriate context — new lump + weight loss = cancer until proven otherwise. Testicular exam in young men.

Mental state

PHQ-9, cognitive screen (MMSE/MoCA if elderly), eating disorder signs (Russell's sign, parotid enlargement, lanugo hair)

Virchow's node (left supraclavicular lymphadenopathy — Troisier's sign) is a highly significant finding indicating metastatic upper GI, lung, or other intra-abdominal malignancy — this is an urgent 2WW finding. Russell's sign (calluses on dorsum of knuckles from self-induced vomiting) and parotid enlargement suggest bulimia nervosa. Rectal examination is mandatory in weight loss with any change in bowel habit — it detects approximately 10% of rectal cancers that would otherwise be missed on sigmoidoscopy alone.

Diagnose

Investigations — Systematic Screen

Done

Bloods — all patients

FBC U&E LFTs TFTs CRP/ESR HbA1c Calcium Albumin (malnutrition marker)

Cancer screen

PSA (men >50) · Serum protein electrophoresis (age >50 + bone pain/fatigue) · CEA / CA-125 only if specific clinical indication — not routine cancer markers

Malabsorption screen

Anti-TTG IgA + IgA level (coeliac) · Faecal elastase (exocrine pancreatic insufficiency) · B12 / folate · Iron studies

Infection screen

HIV test (offer universally per NICE) · CXR (TB, lung cancer, heart failure, lymphoma) · Urine MC&S · Blood cultures if febrile

Imaging

CXR — all patients (lung cancer, TB, heart failure, lymphadenopathy). USS abdomen/pelvis if abdominal symptoms, jaundice, hepatomegaly. CT organised via 2WW pathway.

NOT routinely

CA-19-9, AFP, CEA without specific clinical indication — poor specificity, causes anxiety and over-investigation. PSA in symptomatic prostate disease only.

CXR is the single highest-yield investigation in unexplained weight loss — it identifies lung cancer, TB (now re-emerging in UK cities), heart failure, and mediastinal lymphadenopathy in a single, fast, low-cost test. Serum albumin <35 g/L is a powerful predictor of malnutrition and increased mortality risk — it should prompt dietitian referral and consideration of nutritional supplementation. Routine cancer markers (CEA, CA-125, AFP) have poor specificity and low positive predictive value in the absence of clinical features — they generate more false positives than true positives in unselected patients.

Refer

Referral — 2WW and Urgent Pathways

Done

999 / same-day

Severe malnutrition (BMI <15), haemodynamic instability from GI bleeding, sepsis with weight loss, acute decompensation

2WW upper GI

Dysphagia, vomiting, upper abdominal pain/mass + weight loss. Age ≥55 + weight loss + upper abdominal symptoms.

2WW colorectal

Age ≥40 + rectal bleeding + unexplained weight loss or change in bowel habit

2WW lung

Haemoptysis any age. Age ≥40 + two of: weight loss, fatigue, cough, dyspnoea, chest/shoulder pain

2WW haematology

Unexplained weight loss + night sweats + lymphadenopathy (B-symptoms)

Eating disorders

Anorexia nervosa / ARFID / bulimia → CRISIS referral if BMI <15 or medically unstable. BEAT eating disorder referral for stable cases. Do NOT manage alone in primary care.

Dietitian

All patients with significant weight loss + malnutrition risk — MUST score (Malnutrition Universal Screening Tool) ≥2 → dietitian referral + nutritional supplementation

NICE NG12 2WW thresholds are based on positive predictive value — the combinations listed carry ≥3% PPV for the relevant cancer. Anorexia nervosa has the highest mortality of any psychiatric disorder (5–10% lifetime) — BMI <15 represents a medical emergency requiring inpatient treatment. Malnutrition affects 3 million people in the UK (BAPEN data) — MUST scoring takes <5 minutes and identifies those needing nutritional supplementation and dietitian input. Delaying dietitian referral worsens outcomes in cancer and chronic disease.

Treat

GP Management — Nutritional Support & Condition-Specific

Done

Malnutrition (MUST ≥2)

Oral nutritional supplements

Ensure Plus / Fortisip 200 kcal supplement BD–TDS (prescribable on FP10 via ACBS). Dietitian input for individualised plan. Protein target 1–1.5 g/kg/day.

Hyperthyroidism

Carbimazole 20–40 mg OD

Start only if diagnosis confirmed. Refer endocrinology concurrently. Check FBC before starting (agranulocytosis risk). Titration regime preferred.

Coeliac disease

Gluten-free diet

Life-long strict GFD. Dietitian referral essential. Check B12, folate, iron, vitamin D, calcium — often deficient. Annual review including coeliac antibody titre.

DepressionSertraline 50 mg OD + IAPT referral. Weight typically recovers as depression responds. Monitor weight monthly. If severe anorexia + depression → psychiatric referral.

Pancreatic insufficiencyCreon (pancreatic enzyme replacement) — dose adjusted to fat content of meals. Dietitian involvement. Address cause (chronic pancreatitis, pancreatic cancer).

Unexplained weight lossWatchful waiting + 3-monthly weight review + repeat bloods at 3 months if initial investigations normal. Document clearly. Annual review for 2 years.

Oral nutritional supplements (ONS) prescribed on FP10 are ACBS-approved and represent a cost-effective intervention for malnutrition — they reduce hospital admissions, infection rates, and mortality in malnourished patients. Carbimazole carries 0.2–0.5% risk of agranulocytosis — patients must be warned to seek immediate review if they develop sore throat or fever and an FBC arranged urgently. Strict lifelong gluten-free diet resolves most coeliac symptoms and normalises intestinal architecture — 30% of patients achieve remission within 3 months and recover lost weight fully.

Lifestyle

Nutritional Rehabilitation & Support

Done

Nutritional fortification Add calories to food — butter, full-fat milk, cheese, nut butters, avocado. Aim 500 kcal surplus above estimated requirements. Small frequent meals if appetite poor.

Social eating Eating alone reduces food intake by 30%. Encourage meals with family, friends, or community dining. Refer to local community meals service if socially isolated elderly patient.

Appetite stimulation Small portions, favourite foods, timing meals with social occasion. Megestrol acetate (appetite stimulant) in cancer cachexia — specialist use only. Mirtazapine increases appetite as side effect — useful in depression + weight loss.

Exercise (preserve muscle) Resistance exercise preserves muscle mass during weight loss. Even light walking + gentle strength training prevents sarcopaenia. Physiotherapy referral if severely deconditioned.

Alcohol review Alcohol displaces nutrition (empty calories + poor absorption). AUDIT-C. Alcohol dependence → alcohol specialist service referral. B1 (thiamine) supplementation if alcohol excess (Pabrinex in clinic if deficiency suspected).

Food insecurity Assess practical barriers — finances, ability to shop/cook, dentition (poor teeth = reduced intake). Signpost to local food banks, social prescribing, Meals on Wheels, community care.

Dental review Poor dentition is a major underdiagnosed cause of weight loss in elderly — pain on chewing reduces intake. Urgent dental referral if significant dental disease.

MUST monitoring Repeat MUST score monthly in patients with active weight loss. Weight trend chart — GP clinical system weight record is an underused resource for monitoring.

Food insecurity affects approximately 8% of UK adults (Food Foundation 2023) and is significantly higher in elderly, disabled, and low-income patients — it is a common and completely reversible cause of weight loss that is missed without direct questioning. Sarcopaenia (muscle loss) associated with malnutrition is a major predictor of functional decline and mortality in the elderly — resistance exercise alongside nutritional rehabilitation preserves muscle far better than nutrition alone. Mirtazapine's weight-gain side effect (mediated by H1 and 5-HT2C antagonism) makes it a preferred antidepressant in elderly depressed patients with weight loss.

Safety

Follow-Up & Safety-Netting

Done

2–4 weeks

Weight check — is weight loss continuing or stabilising? Review investigation results. Any new symptoms pointing to specific diagnosis?

3 months

Full reassessment if no diagnosis found initially. Repeat bloods. New symptoms may have emerged. Repeat CXR if initial normal but weight loss continues.

6–12 months

Annual weight monitoring for 2 years after unexplained weight loss — malignancy risk remains elevated even after negative initial workup

Carbimazole monitoring

TFTs at 4–6 weeks after starting, then 2–3 monthly. FBC if sore throat/fever (agranulocytosis). Refer endocrinology for definitive treatment (radioiodine or surgery).

Anorexia nervosa

Weekly weight, SUSS score (Sick, Control, One Stone, Fat, Food), physical health parameters (bradycardia, BP, ECG — QTc prolongation) if managing in primary care

999 safety-net

Haematemesis / melaena, haemoptysis with haemodynamic compromise, collapse, severe confusion

Same-day GP

Rapid acceleration of weight loss, new alarm symptom (dysphagia, haemoptysis, rectal bleeding), jaundice appearing, BMI falling below 15

Ongoing cancer surveillance after negative initial investigation is essential — a 5-year prospective study found that 12% of patients with unexplained weight loss diagnosed with no cause subsequently developed malignancy within 2 years. "No cause found" is not a reassuring endpoint — it requires structured monitoring. In anorexia nervosa, bradycardia (<50 bpm) and QTc prolongation are the most life-threatening signs — ECG is a key monitoring tool and QTc >450ms warrants emergency psychiatric admission. The SUSS questionnaire is a validated 5-question screen for eating disorder severity usable in primary care.